Archean Chemical Industries Limited

BSE: ACI543657ISIN INE128X01021

Commodities
Specialty Chemicals
BSE 1000

BSE listing

Share price

₹466.80+4.75 (+1.03%)

as of 18 Sep 2026

52W high: ₹720.00
52W low: ₹447.55
Off 52W high: -35.17%
1M return: -7.72%
3M return: -11.57%
6M return: -22.25%
1Y return: -32.86%
20D avg volume: 1,45,510
50 DMA: ₹515.33
200 DMA: ₹544.60

Key ratios Consolidated

Market cap: ₹5,763 Cr
Current price: ₹466.80
52W high / low: ₹720.00 / ₹447.55
Face value: ₹2.00
P/E: 60.27
P/B: —
EPS (TTM): ₹7.75
Book value / share: —
ROE: —
ROCE: 7.80%
Operating margin: —
Net margin: —
Debt / equity: 0.24
Net debt: ₹425.15 Cr
Interest cover: 6.71
Dividend yield: 0.54%
Dividend / share (TTM): ₹2.50
Payout: 32.26%
Cash conversion cycle: 80.1 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	327.20	300.94	254.56	233.18	292.36	345.58	—
	5.61	5.39	6.95	6.38	8.23	7.81	—
	288.59	290.48	228.19	199.65	242.58	278.71	—
	38.50	25.52	15.43	12.67	34.06	22.87	—
	0.00	0.00	0.00	0.00	16.52	0.00	—
	19.30	21.30	17.30	16.85	18.73	19.59	—
	5.45	10.43	4.42	5.52	5.38	0.29	—
	23.20	22.80	23.60	23.55	22.94	21.14	—
	210.03	196.67	183.80	153.60	169.74	225.34	—
	44.22	15.86	33.33	39.91	58.01	74.67	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	44.22	15.86	33.33	39.91	58.01	74.67	—
	13.86	3.63	9.33	10.87	17.86	20.93	—
	30.35	12.23	24.00	29.04	40.14	53.75	—
	2.48	1.13	1.92	2.36	3.25	4.33	—
Key metrics
	72.87	49.09	61.35	68.98	86.33	96.10	—
	22.30%	16.30%	24.10%	29.60%	29.50%	27.80%	—
	9.30%	4.10%	9.40%	12.50%	13.70%	15.60%	—
	—	1.20%	—	2.00%	—	3.40%	—
	11.90%	-12.90%	—	—	—	—	—
	-24.40%	-77.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,116	1,081	1,041	—
	24.33	26.95	37.28	—
	1,007	960.90	814.35	—
	92.12	87.68	62.94	—
	0.00	16.52	0.00	—
	74.75	74.19	61.05	—
	25.82	25.75	8.10	—
	93.15	92.89	79.38	—
	744.10	703.81	673.60	—
	133.32	147.10	263.95	—
	0.00	0.00	-40.18	—
	133.32	147.10	223.77	—
	37.69	41.69	61.62	—
	95.62	105.41	162.14	—
	7.89	8.66	13.13	—
Key metrics
	252.29	265.74	311.25	—
	22.61%	24.60%	29.90%	—
	8.57%	9.80%	15.60%	—
	—	7.80%	10.60%	—
	—	3.80%	—	—
	—	-35.00%	—	—
	—	-242.53	-87.34	—
	—	1.32	1.09	—
	—	0.24	0.10	—
	—	425.15	137.52	—
	—	80.1	79.8	—
Balance sheet
	—	2,665	2,393	—
	—	531.38	691.39	—
	—	41.23	40.54	—
	—	127.28	164.57	—
	—	214.92	168.13	—
	—	114.31	82.03	—
	—	1,383	1,378	—
	—	105.23	105.05	—
	—	438.35	197.28	—
	—	466.38	178.06	—
	—	294.70	26.46	—
	—	171.68	151.60	—
	—	1,933	1,864	—
Cash flow
	—	139.63	176.23	—
	—	-292.85	-246.23	—
	—	153.91	64.98	—
	—	382.16	263.57	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	315.93	292.28	249.87	220.76	278.63	321.77	—
	16.14	12.42	10.94	11.02	12.82	11.56	—
	276.76	262.80	215.06	180.68	219.94	253.75	—
	30.69	17.13	10.64	10.38	14.45	7.72	—
	0.00	0.00	0.00	0.00	16.52	0.00	—
	16.20	16.39	15.03	14.42	16.50	14.47	—
	8.64	5.02	3.74	4.50	4.46	2.91	—
	19.91	19.47	20.37	20.39	19.82	18.62	—
	206.30	189.45	180.37	150.35	166.36	223.21	—
	55.31	41.90	45.75	51.10	71.51	79.58	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	55.31	41.90	45.75	51.10	71.51	79.58	—
	14.79	12.14	11.45	12.64	19.66	21.27	—
	40.53	29.76	34.30	38.46	51.85	58.31	—
	3.28	2.41	2.78	3.12	4.20	4.72	—
Key metrics
	83.86	66.39	69.86	75.99	95.79	101.11	—
	26.50%	22.70%	28.00%	34.40%	34.40%	31.40%	—
	12.80%	10.20%	13.70%	17.40%	18.60%	18.10%	—
	—	2.10%	—	2.60%	—	3.90%	—
	13.40%	-9.20%	—	—	—	—	—
	-21.80%	-49.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,079	1,042	1,014	—
	50.52	47.21	49.66	—
	935.30	878.49	773.50	—
	68.84	52.60	38.88	—
	0.00	16.52	0.00	—
	62.04	62.35	53.93	—
	21.90	17.72	9.11	—
	80.14	80.06	73.06	—
	726.47	686.54	665.80	—
	194.06	210.26	289.95	—
	0.00	0.00	-40.18	—
	194.06	210.26	249.77	—
	51.02	55.89	64.84	—
	143.05	154.37	184.92	—
	11.59	12.51	14.98	—
Key metrics
	296.10	308.04	331.94	—
	27.45%	29.60%	32.70%	—
	13.26%	14.80%	18.20%	—
	—	10.20%	12.30%	—
	—	2.70%	—	—
	—	-16.50%	—	—
	—	127.55	74.36	—
	—	1.22	0.91	—
	—	0.16	0.06	—
	—	298.16	71.80	—
	—	83.8	78.5	—
Balance sheet
	—	2,571	2,249	—
	—	464.43	651.58	—
	—	23.39	35.93	—
	—	135.85	171.95	—
	—	199.46	153.93	—
	—	72.14	60.11	—
	—	1,067	1,071	—
	—	96.03	107.74	—
	—	330.40	145.42	—
	—	321.55	107.73	—
	—	219.41	23.03	—
	—	102.14	84.70	—
	—	1,998	1,880	—
Cash flow
	—	189.04	169.15	—
	—	-339.48	-195.88	—
	—	137.90	18.78	—
	—	61.49	94.79	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 53.43%

Holder	Type	Holding	Previous	Change
Chemikas Speciality LLP	Promoter	30.53%	—	—
Pendurthi Ranjit	Promoter	22.90%	—	—
Sbi Small Cap Fund	Public	6.88%	—	—
Dsp Small Cap Fund	Public	3.06%	—	—
Hdfc Mutual Fund - Hdfc Multi Cap Fund	Public	3.00%	—	—
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio	Public	2.46%	—	—
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund	Public	1.11%	—	—
Icici Lombard General Insurance Company Ltd	Public	1.06%	—	—
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110	Public	1.06%	—	—
Icici Prudential Multicap Fund	Public	1.01%	—	—
Pendurthi Ravi	Promoter	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund5 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Earnings call Transcript7 Aug 2026 · Company Update / Earnings Call Transcript
Earnings Call Recording3 Aug 2026 · Company Update / Analyst / Investor Meet
Investor Presentation1 Aug 2026 · Company Update / Investor Presentation
Newspaper Publication of Financial Result31 Jul 2026 · Company Update / Newspaper Publication
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP31 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.30 Jul 2026 · Result / Financial Results
Outcome of the Board Meeting held on July 30, 2026 1. The Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Pursuant to Regulation 33(3) of ....30 Jul 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Schedule for Earnings Call28 Jul 2026 · Company Update / Analyst / Investor Meet
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2026 for Chemikas Speciality LLP24 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Reconciliation of share capital audit18 Jul 2026 · Company Update / General
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve un-audited Standalone ....18 Jul 2026 · Board Meeting / Board Meeting
Clarification on increase in the volume movement of Security across Exchanges16 Jul 2026 · Company Update / General
The Exchange has sought clarification from Archean Chemical Industries Ltd on July 16, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.16 Jul 2026 · Company Update / Clarification
General Update15 Jul 2026 · Company Update / General
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP13 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP13 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations6 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 04, 2026 for Chemikas Speciality LLP6 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Intimation of order under Section 270A of the Income Tax Act, 19611 Jul 2026 · Company Update / General
Closure of Trading Window23 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd13 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Voting Results of 17th Annual General Meeting (AGM) of the Company along with Scrutinizer''s Report12 Jun 2026 · AGM/EGM / AGM
Re-appointment of M/s PKF Sridhar & Santhanam LLP, as the Statutory Auditor of the Company. Re-appointment of Mr. Kandheri Munuswamy Mohandass and Mr. Chittoor Ghatambu Sethuram as the ....12 Jun 2026 · Company Update / Change in Management
Proceedings of the 17th Annual General Meeting (AGM)12 Jun 2026 · AGM/EGM / AGM
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 12, 2026 for Chemikas Speciality LLP12 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Intimation of Schedule of Analyst / Institutional Investor meetings7 Jun 2026 · Company Update / Analyst / Investor Meet
Subscription to the Right Issue of equity shares of its Wholly Owned Subsidiary, Acume Chemicals Private Limited30 May 2026 · Company Update / Acquisition
Annual Secretarial Compliance29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 25, 2026 for Chemikas Speciality LLP26 May 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Schedule of Analyst / Institutional Investor meetings-360 ONE Capital (B&K) 16th Annual Investor Conference-Trinity India 202625 May 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication of Notice for the 17TH AGM of the Company22 May 2026 · Company Update / Newspaper Publication
Annual Report 2025-2622 May 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed the Annual Report 2025-26 of Archean Chemical Industries Limited.21 May 2026 · AGM/EGM / AGM
Please find enclosed the Business Responsibility and Sustainability Report 2025-26 forming part of Annual Report 2025-26.21 May 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed the Notice of 17th AGM to be held on Friday, June 12, 2026 @ 10.00 AM through VC/OAVM.21 May 2026 · AGM/EGM / AGM
Earnings Call Transcript19 May 2026 · Company Update / Earnings Call Transcript
Newspaper publication of the Audited (Standalone & Consolidate) Financial Results of the Company13 May 2026 · Company Update / Newspaper Publication

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.5000	5 Jun 2026	5 Jun 2026	—
Final Dividend - Rs. - 3.0000	26 May 2025	26 May 2025	—

Board meetings

30 Jul 2026 Board Meeting - Financial Results